SIRONA is a randomised controlled trial comparing sirolimus-coated balloon angioplasty with paclitaxel coated balloon angioplasty in patients with femoropopliteal artery disease, an area traditionally dominated by paclitaxel based therapies. Concept Medical Inc., a global leader in drug delivery technologies for vascular interventions has announced the presentation of preliminary 3-year
Concept Medical, a globally recognised leader in innovative medical devices, has achieved a remarkable milestone by becoming the first medical company to receive its fourth Investigational Device Exemption (IDE) approval from the United States Food and Drug Administration (USFDA) to treat Superficial Femoral Arteries (SFA). The
In BTK indication for its Sirolimus Coated Balloon Magic Touch PTA Concept Medical Inc. (CMI) is granted the second Investigational Device Exemption (IDE) approval in Below the Knee (BTK) indication, for its Sirolimus Coated Balloon Magic Touch PTA. This came after the company got its first
